Laboratory Corp of America Holdings (NYSE: LH) posted Q3 revenues of $3.61 billion, a decrease of 11.2% Y/Y, missing the consensus of $3.79 billion. The 10.7% decrease in organic revenue was driven by an 11.8% decrease in COVID-19 Testing, partially offset by a 1.1% increase in the company's organic Base Business. "We continue to manage inflationary headwinds and labor constraints through our LaunchPad initiatives. And, we are accelerating the planned spin-off of our Clinical Development busines
Labcorp CEO Adam Schechter joined Yahoo Finance's All Markets Summit to discuss the growth opportunities in diagnostic testings and lessons learned during the COVID-19 pandemic.
In this article, we will look at the 10 best value stocks to buy for the next decade. If you want to skip reading about the comparison between the returns generated by value and growth stocks, go directly to 5 Best Value Stocks to Buy for the Next Decade. During the five years from 2017 […]